AMBEA AB |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.72 SEK | -0.03% |
|
+0.41% | +38.12% |
| May. 16 | Ambea Completes SEK187 Million Share Buyback; New Program Set to Launch | MT |
| May. 15 | Tranche Update on Ambea AB (OM:AMBEA)'s Equity Buyback Plan announced on February 28, 2024. | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- With a P/E ratio at 11.82 for the current year and 10.12 for next year, earnings multiples are highly attractive compared with competitors.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +38.12% | 597M | B- | ||
| +24.66% | 88.38B | C+ | ||
| -21.76% | 77.56B | B- | ||
| +8.73% | 28.74B | C+ | ||
| +7.45% | 18.45B | A- | ||
| -13.50% | 16.57B | B | ||
| +3.23% | 15.81B | A- | ||
| +77.51% | 13.65B | C- | ||
| +76.96% | 13.06B | C+ | ||
| +4.61% | 12.61B | A- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- AMBEA Stock
- Ratings Ambea AB
